April 29th 2025
The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Growth in Single-Use Technology Video
May 30th 2013Rita Peters, Editorial Director for Pharmaceutical Technology and BioPharm Inernational talks with Mani Krishnan, director of systems at EMD Millipore live at Interphex 2013 about single-use technology. In this interview they discuss areas of growth in single-use technology as well as reservations that some companies have to switching to single-use systems Krishnan identifies a few technology advances that are overcoming these objections as well as decision-making strategies for facilities considering a switch to a single-use system.
Should Regulation of Combination Products Become More Centralized in Europe?
May 1st 2013While there are those who want combination products to be controlled by a centralized pharmaceutical-type approval system, the majority of the medical technology industry wants to retain a decentralized device-focused approach.
BioOutsource Opens New Facility in Cambridge, Massachusetts
April 24th 2013BioOutsource, a contract testing services provider to the biopharmaceutical industry, has opened a new facility in Cambridge, Massachusetts. The facility marks the company's first North American offices, which were opened in response to increasing demand for the company's bioanalytical and biosafety services, particularly in the field of biologic and biosimilar characterisation.
Astellas and Ambrx Collaborate on Antibody Drug Conjugates for Oncology
April 8th 2013Astellas and Ambrx have entered into a collaboration to discover and develop novel antibody drug conjugates (ADCs) for an undisclosed number of targets in oncology. ADCs enable targeted delivery of drugs to the target tissue.
Growth Kinetics of Human Mesenchymal Stem Cells in a 3-L Single-Use, Stirred-Tank Bioreactor
The authors describe the growth characteristics of human mesenchymal stem cells cultured in a stirred-tank bioreactor.